image of Ruth Siew
  • Telehealth Visits
bch logo

Ruth Siew, MD

Pediatric Pulmonology
Pediatric Pulmonology Oakland
877-822-4453
image of Ruth Siew
image of Ruth Siew
bch logo

Ruth Siew, MD

Pediatric Pulmonology
Pediatric Pulmonology Oakland
877-822-4453
  • Telehealth Visits

On this page

About me

Dr. Ruth Siew is a pediatric pulmonologist who cares for children with a variety of lung and breathing concerns, including asthma, recurrent respiratory infections, chronic lung disease, congenital lung abnormalities (those present at birth), respiratory complications due to prematurity, and conditions that make them dependent on technology for breathing. To ensure comprehensive care, she collaborates with specialists in gastroenterology; pediatric feeding issues; and ear, nose and throat disorders.

Siew earned her medical degree at the University of Washington School of Medicine. She completed a residency in pediatrics and a fellowship in pediatric pulmonology at the University of California, San Diego.

Education

Board Certification

  • Pediatric Pulmonology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Pediatric Pulmonology, University of California San Diego - Pediatrics

Residency

  • Pediatrics, University of California Medical Center San Diego

Internship

  • Pediatrics, University of California Medical Center San Diego

School

  • MD, University of Washington School of Medicine

Academic Title

  • Health Sciences Clinical Professor

Care Keywords

  • Services
    • Pediatric Pulmonology

Locations

    Provider Research Listing

    Browse clinical trials and publications by this provider

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.